Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-α and ER-β) in human endometrial hyperplasia-Reference-Cited by-同舟云学术

Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-α and ER-β) in human endometrial hyperplasia

Published:2006-05 Issue:2 Volume:101 Page:214-223
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Vereide Anne Beate,Kaino Turid,Sager Georg,Arnes Marit,Ørbo Anne

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference46 articles.

1. Progestin regulation of cellular proliferation;Clarke;Endocr. Rev.,1990

2. Physiological action of progesterone in target tissues;Graham;Endocr. Rev.,1997

3. Endometrial carcinoma;Rose;N. Engl. J. Med.,1996

4. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients;Kurman;Cancer,1985

5. Molecular mechanisms of action of steroid/thyroid receptor superfamily members;Tsai;Annu. Rev. Biochem.,1994

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between steroid receptor expression and response to progestational therapy in patients with atypical endometrial hyperplasia or cancer;Gynecologic Oncology Reports;2024-06

2. The impact of previous conservative treatment of atypical hyperplasia on pregnancy outcomes after IVF/ICSI–embryo transfer: a propensity score-matched retrospective cohort study;Human Reproduction;2023-10-25

3. Advances in the molecular mechanisms underlying progestin resistance in endometrial cancer;Fundamental Research;2023-09

4. Efficacy of Oral Medications or Intrauterine Device-Delivered Progestin in Patients with Endometrial Hyperplasia with or without Atypia: A Network Meta-Analysis;Journal of Clinical Medicine;2023-04-19

5. Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer;Cancers;2022-10-06